Riskpilot← Back to searchSign inGet full accessJUOMEDIC AB
ABActiveOrg 5566364450Yttervägen 3General medical practice activities · NACE 8621Est. 20022 employees
Revenue 2025
SEK 9,3M
+44% vs 2024
EBITDA margin
69.2%
+59% vs 2024
Equity ratio
66.8%
Financial strength
Net profit 2025
SEK 3,2M
+26% vs 2024
| Revenue | SEK 9,3M | +44% |
| EBITDA | SEK 6,4M | +59% |
| Net profit | SEK 3,2M | +26% |
| Total assets | SEK 21,6M | +26% |
| Equity | SEK 14,4M | +22% |
| Employees | 2 | — |
Legal name
JUOMEDIC AB
Org number
5566364450
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
5 december 2002
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva utbildning och läkarverksamhet, förvaltning av värdepapper jämte därmed förenlig verksamhet.
Address
Yttervägen 3
Phone
+46705771804
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 6 531 | 6 578 | 5 475 | 5 554 | 5 653 | 6 222 | 6 452 | 9 306 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 691 | 2 585 | 4 173 | 4 195 | 3 072 | 3 216 | 3 380 | 3 949 | 4 060 | 6 439 |
| Depreciation & amort. | −41 | −266 | −408 | −600 | −614 | −457 | −397 | −269 | −291 | −329 |
| EBIT | 650 | 2 319 | 3 765 | 3 595 | 2 458 | 2 759 | 2 983 | 3 680 | 3 769 | 6 110 |
| Net financials | −1 | — | −449 | −1 148 | −1 351 | 2 414 | −322 | −1 425 | −601 | −1 085 |
| Profit before tax | 648 | 1 739 | 1 920 | 2 032 | 1 885 | 3 754 | 2 176 | 2 620 | 3 211 | 4 531 |
| Tax | −143 | −384 | −428 | −463 | −409 | −807 | −457 | −557 | −691 | −1 358 |
| Net profit | 505 | 1 355 | 1 492 | 1 569 | 1 476 | 2 947 | 1 719 | 2 063 | 2 520 | 3 173 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 135 | 4 246 | 5 594 | 7 616 | 7 732 | 11 762 | 13 447 | 15 030 | 17 156 | 21 579 |
| Equity | 936 | 1 531 | 2 863 | 3 786 | 4 562 | 7 016 | 8 227 | 9 786 | 11 773 | 14 416 |
| Long-term debt | 0 | 1 484 | 0 | 250 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 199 | 651 | 755 | 635 | 309 | 466 | 450 | 246 | 93 | 864 |
| Total debt | 199 | 2 135 | 755 | 885 | 309 | 466 | 450 | 246 | 93 | 864 |
EBITDA margin
69.2%
This company
15.8%
Market median
+338% vs market
20162025
Equity ratio
66.8%
This company
38.2%
Market median
+75% vs market
20162025
Return on equity
22.0%
This company
18.4%
Market median
+20% vs market
20162025
Net profit margin
34.1%
This company
8.1%
Market median
+321% vs market
20162025
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20162025
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-05-01 – 2016-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of JUOMEDIC AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Fredrik Anders Törnquist | Audit | 0 companies |
| Pär Jonas Ottosson | Deputy Board Member | 0 companies |
| Johan Fredrik Ottosson | Board of Directors | 0 companies |